Skip to main content

Table 1 Baseline patient characteristics and perioperative data for all patient and by group allocation, data are summarized by number (%), median (interquartile range) or mean (standard deviation)

From: Opioid-reduced anesthesia based on esketamine in gynecological day surgery: a randomized double-blind controlled study

 

All patients (n = 141)

Group C (n = 48)

Group MO (n = 49)

Group LO (n = 44)

p-Value

Age

41.89 ± 9.29

41.58 ± 7.41

41.49 ± 9.85

42.68 ± 10.58

0.796

Weight (kg)

61.08 ± 7.71

60.71 ± 6.67

60.81 ± 8.76

61.8 ± 7.66

0.762

BMI (kg/m2)

23.37 ± 2.96

23.09 ± 2.92

22.98 ± 2.94

24.1 ± 2.95

0.139

ASA score

    

0.221

  I

66 (46.8%)

27 (56.3%)

19 (38.8%)

20 (45.5%)

 

  II

75 (53.2%)

21 (43.8%)

30 (61.2%)

24 (54.5%)

 

PONV risk score

    

0.956

  2

84 (59.6%)

28 (58.3%)

30 (61.2%)

26 (59.1%)

 

  3

57 (40.4%)

20 (41.7%)

19 (38.8%)

18 (40.9%)

 

Surgical procedure

    

0.497

  Hysteroscopy

107 (75.9%)

36 (75%)

35 (71.4%)

36 (81.8%)

 

  Cervical conization

34 (24.1%)

12 (25%)

14 (28.6%)

8 (18.2%)

 

  Anesthesia Time (min)

20 (14, 27.5)

20 (14, 34.5)

18 (13, 25.5)

21 (15, 29.5)

0.222

  Extubation time (min)

5 (4, 6)

5 (3, 6)

5 (4, 6)

5 (3, 6)

0.692

  Length of postoperative hospital stay (h)

3 (2, 4)

3.5 (2, 4)

3 (2, 4)

2.5 (2, 3.5)

0.055

  Length of stay in the PACU (min)

50 (30, 80)

42.5 (25, 73.75)

50 (30, 105)

60 (36.25, 88.75)*

0.036

  Alfentanil consumption (ug/kg)

20 (10, 25.6)

30.3 (25.2, 37.8)

20 (18.69, 20)a

10 (9.75, 10)*

0.000

  1. *Compared with Group C, p < 0.05